Unique Access Medical (UAM) is excited to announce our new venture into a search for the potential treatment for Ataxia giving new hope to all Ataxia patients.
UAM, in collaboration with Autologous Stem Cell Treatment (ASC), is seeking to provide and develop an innovative Cellular Treatment for patients suffering from Ataxia. Our collaborator, ASC, based in Australia, is a Regenerative Treatment facilitator, who has lawfully carried out more than 400 cellular treatments since 2012. In all attempt to avoid genetic manipulation, ASC’s innovative technological method to utilise the patient’s own blood to culture cells are both safe and effective.
We strongly believe in the utilised cell products’ ability to regenerate and repair the damaged neurons, and thus, contribute to the improvements and wellbeing of Ataxia patients. UAM, with full confidence, supports this venture in our attempt to provide patients with full access to a beneficial treatment.
UAM is now recruiting up to 10 patients suffering from Ataxia to be a part of the treatment plan which will be carried out in Bangkok, Thailand in February-March 2018. Patients will be given access to a special discount provided on a first come first serve basis only. Please do not hesitate to contact us to learn more about the opportunity and to secure a spot for yourself or your loved-one.
You can reach us at [email protected] for any further information and to reserve your slot for a free consultation with our medical experts.
